In Memory of Kirsty Duncan: A Life Devoted to Science, Health, and Equity

Afreen Shariff Starts a New Position as Chair at ASCO for the ASPIRE Community of Practice

Breakthrough Innovations in Frontline TNBC Care - The Breast Friends Podcast

How the European Code Against Cancer Can Reduce Cancer Risk in Greece - ELLOK

Community Oncology Alliance Shares 2025 End of Year Update on Advocacy and Practice Support

Oncology News, Insights, Stories by OncoDaily

Global Oncothon
OncoDaily

Global Oncothon 2026

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy
FDA Approvals

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

PRADO Trial: Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma—5-Year Survival and Biomarker Analysis
Oncolibrary

PRADO Trial: Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma—5-Year Survival and Biomarker Analysis

Australia’s Pharma Market Poised to Hit $24.5B by 2030

Christian Blank: 5-year Survival and Biomarker Analysis for Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma

Vivek Subbiah: Have Orphans in Rare Tumor Precision Oncology Been Adopted?

Jay Bhattacharya: NIH Launches Initiative to Elevate Replication and Reproducibility in Research

"Building Bridges of Care” at the 10th Annual Conference of ELLOK

South Korea Secures $4.2b In Biologics Agreements

Dario Trapani on Making Cancer Innovation Equitable and Sustainable - CancerWorld

OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Ulrika Årehed Kågström

Ulrika Årehed Kågström: Evaluating Sweden’s Progress on the EU Beating Cancer Plan

Jasmine Kamboj: Excited to Join the Global OncoThon Hosted by OncoDaily

Launching the 2026 GICR Interactive Webinar Series on Cancer Registration - IARC

Cara Bohon: NCCN Adds Collaborative Care Model to Distress Management Guidelines

Amplifying Cancer Survivorship Voices in Central Africa for World Cancer Day 2026 - AORTIC-Africa

Refresher Course on Hean and Neck Cancer - European School of Oncology 

Miriam Mikhail Lette: Limited ECR Spots for LMIC Applicants

FDA Approvals
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

New Hope for NUT Carcinoma: FDA Grants Orphan Drug Status to ZEN-3694

FDA approved Durvalumab plus FLOT for resectable gastric or GEJ adenocarcinoma

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop

British Society of Haematology

25 Feb
British Society of Haematology

Escalation or De-Escalation? Strategies in HER2+ Breast Cancer Treatment

Sharing Progress in Cancer Care

23 Apr
Breast Cancer Treatment

38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026)

European Organisation for Research and Treatment of Cancer

18 Nov
EORTC-NCI-AACR

Clinical Trial Statistics for Non-Statisticians Workshop

European Organisation for Research and Treatment of Cancer

09 Jun
Clinical Trial Statistics

15th European Breast Cancer Conference (EBCC-15)

European Organisation for Research and Treatment of Cancer

25 Mar
Breast Cancer Conference

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

OncoDaily TV
Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Susan G. Komen

How Is Susan G. Komen Changing the Future of Breast Cancer Care?

Not To Miss
ELLOK treatment of brain tumors

"Building Bridges of Care” at the 10th Annual Conference of ELLOK

ELLOK to Host 10th Annual Conference on People-Centred Cancer Care in Athens 2026

Oncology This Week: OncoDaily Weekly Jan 19-25, 2026

Highlights from How I Treat Cervical Cancer in 2026

10 Posts Not To Miss From BGICC 2026: Part 2

10 Posts Not To Miss From BGICC 2026, Part 1

Oncology This Week: OncoDaily Weekly Jan 12–18, 2026

OncoGrants
Karolinska Translational Seed Grant in Oncology

Karolinska Translational Seed Grant in Oncology 2026

AECC Excellence Programs Oncology Funding

AECC Excellence Programs Oncology Funding 2026

AECC Cancer Prevention Biology Oncology Grant

AECC Cancer Prevention Biology Oncology Grant 2026

AECC INNOVA Oncology Innovation Grant

AECC INNOVA Oncology Innovation Grant 2026

Mays Cancer Center Summer Oncology Research Program

Mays Cancer Center Summer Oncology Research Program 2026

Cure Childhood Cancer Translation to CURE Oncology Award 2026

Cure Childhood Cancer Translation to CURE Oncology Award 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Ana Filipa Martins Ferreira Varges Gomes

Ana Filipa Martins Ferreira Varges Gomes

Oncologists Location São Paulo, Brazil
Fatma Ben Abid

Fatma Ben Abid

Oncologists Location Rabat, Morocco
Garik Sagoyan

Garik Sagoyan

Oncologists Location Moscow, Russian Federation
Rahat Ul Ain

Rahat Ul Ain

Oncologists Location Lahore, Pakistan
Enrique Soto Perez de Celis

Enrique Soto Pérez de Celis

Oncologists Location Aurora, USA
LIdia Schapira

Lidia Schapira

Oncologists Location Stanford, USA
Gabriele Todisco

Gabriele Todisco

Oncologists Location Milan, Italy
Luiz H. de Lima Araujo

Luiz H. de Lima Araujo

Oncologists Location Rio de Janeiro, Brazil

Oncology Drugs
Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

Anbenitamab (KN026): A Deep Dive Into a Bispecific HER2 Antibody Redefining Targeted Therapy

Iza-Bren (EGFR×HER3 ADC): A Patient-Friendly Guide To A New Cancer Treatment

Iza-Bren (EGFR×HER3 ADC): A Next-Generation Dual-Targeted Antibody–Drug Conjugate

AgenT-797 (iNKT): What Patients Need to Know About This New Cancer Immunotherapy

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
JUPITER-06

JUPITER-06 Final Overall Survival and Genomic Biomarker Analysis in Advanced ESCC

JCOG0603

JCOG0603 Long-Term Results: Adjuvant mFOLFOX6 After Hepatectomy in Resectable Colorectal Liver Metastases

Nous-209 vaccine

New Paper Alert: Nous-209 Neoantigen Vaccine for Cancer Interception in Lynch Syndrome

LARA Trial

LARA Trial: Pembrolizumab–Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma

OPBC-07/microNAC

OPBC-07/microNAC: Oncological Outcomes With and Without Axillary Lymph Node Dissection in Patients with Residual Micrometastases After Neoadjuvant Chemotherapy.

NOBEL Trial

NOBEL Trial: Nivolumab Combined With Definitive Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7028

A Novel Evaluation Formula for Plan Quality in Conventional Fractionated and Stereotactic Radiotherapy: Nabaa Efficiency Index (NEI)
Abstracts